Delivery Order SPE2DB24D2018-SPE2DB25FWWC2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,705.32 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets (UU 21S) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,059.09 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,246.44 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets in a 30-count configuration. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,016,928 units of the pharmaceutical product pyridostigmine bromide 30 mg tablets. The contract has a ceiling value of $3,848.05 and a period of performance through March 20, 2024. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Pyridostigmine ER 180 mg tablets in quantities of 30 units, with a ceiling value of $9,787.50. This delivery order, issued under a firm fixed-price arrangement, represents a child contract executed through AmerisourceBergen's broader relationship with DLA. No set-aside designation was applied to this competitive award. The product will be delivered to the vendor's corporate...
- The Defense Logistics Agency Troop Support Medical awarded a $331 firm fixed price delivery order against an unidentified contracting vehicle to Amerisourcebergen Drug Corporation for the supply of 180 bottles of 180mg pyridostigmine bromide tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania within a period of performance spanning from August 10, 2023 to September 7,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,724.08 firm-fixed-price contract is for the supply of pyridostigmine bromide 30 mg tablets, which are used to treat the effects of nerve agent exposure. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pyridostigmine BR 30 mg tablets, with a total ceiling value of $4,717.76 and a performance period through June 24, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pyridostigmine BR 60 MG Tablet 30S, a medical product, with a ceiling value of $1,415.66 and a completion date of June 4, 2025. The contract is designated as a Firm Fixed Price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PYRIDOSTIGMINE BR 60 MG TABLET 30S. The contract has a completion date of July 1, 2025 and a ceiling value of $1,465.41. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWC2Delivery Order
The Defense Logistics Agency awarded a $11,998.92 delivery order to AmerisourceBergen Drug Corp for Pyridostigmine Bromide 60 mg tablets (30-count packaging) on August 7, 2025, with completion expected by August 8, 2025. This competitive award, issued without set-aside designation, reflects a firm fixed price contract type and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's comprehensive IDC vehicle supports global pharmaceutical supply operations for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. Pyridostigmine bromide is an acetylcholinesterase inhibitor commonly used in military medical applications, and this delivery order fulfills specific pharmaceutical requirements within the broader strategic pharmaceutical prime vendor framework that DLA Troop Support maintains to ensure reliable medical supply chains across the defense infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 8/7/25 |